Clinical Trials Directory

Trials / Completed

CompletedNCT06728501

Diabetes Education for Patients With Type 2 Diabetes in Turkmenistan

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
114 (actual)
Sponsor
Ludwig-Maximilians - University of Munich · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to investigate whether structured diabetes mellitus education leads to improved blood glucose control in Turkmenistan.

Detailed description

Diabetes education is not routinely carried out in Turkmenistan. The aim of the study is to investigate whether patients with type 2 diabetes benefit from an International Diabetes Federation (IDF) based education program. Patients will be randomized into a education group and a control group. The education group will receive 4 - 5 hours of education and the control group will only receive general information about diabetes mellitus. After 6 months, it is checked whether the change in the HbA1c value differs between the two groups. Additinal paremeters such as blood pressure, diabetes knowledge and lipids will also be evaluated (secondary parameters).

Conditions

Interventions

TypeNameDescription
BEHAVIORALDiabetes educationPatients receive 5 hours of diabetes education

Timeline

Start date
2022-02-01
Primary completion
2022-07-31
Completion
2022-07-31
First posted
2024-12-11
Last updated
2024-12-11

Locations

1 site across 1 country: Turkmenistan

Source: ClinicalTrials.gov record NCT06728501. Inclusion in this directory is not an endorsement.

Diabetes Education for Patients With Type 2 Diabetes in Turkmenistan (NCT06728501) · Clinical Trials Directory